Siegfried Holding AG

SWX:SFZN1 Stock Report

Market Cap: CHF 4.3b

Siegfried Holding Valuation

Is SFZN1 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of SFZN1 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Discounted Cash Flow
Simply Wall St
CHF 87.66
Fair Value
11.8% overvalued intrinsic discount
11
Number of Analysts

Below Fair Value: SFZN1 (CHF98) is trading above our estimate of fair value (CHF87.66)

Significantly Below Fair Value: SFZN1 is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for SFZN1?

Key metric: As SFZN1 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for SFZN1. This is calculated by dividing SFZN1's market cap by their current earnings.
What is SFZN1's PE Ratio?
PE Ratio26.8x
EarningsCHF 160.06m
Market CapCHF 4.29b

Price to Earnings Ratio vs Peers

How does SFZN1's PE Ratio compare to its peers?

The above table shows the PE ratio for SFZN1 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average41.4x
BANB Bachem Holding
31.4x15.8%CHF 3.8b
TECN Tecan Group
30x17.2%CHF 2.0b
SKAN SKAN Group
38.9x16.3%CHF 1.5b
LONN Lonza Group
65.4x21.2%CHF 41.6b
SFZN1 Siegfried Holding
26.8x9.8%CHF 4.3b

Price-To-Earnings vs Peers: SFZN1 is good value based on its Price-To-Earnings Ratio (26.8x) compared to the peer average (41.4x).

Price to Earnings Ratio vs Industry

How does SFZN1's PE Ratio compare vs other companies in the European Life Sciences Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
SFZN1 26.8xIndustry Avg. 32.3xNo. of Companies4PE020406080100+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: SFZN1 is good value based on its Price-To-Earnings Ratio (26.8x) compared to the European Life Sciences industry average (32.3x).

Price to Earnings Ratio vs Fair Ratio

What is SFZN1's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SFZN1 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio26.8x
Fair PE Ratio19.5x

Price-To-Earnings vs Fair Ratio: SFZN1 is expensive based on its Price-To-Earnings Ratio (26.8x) compared to the estimated Fair Price-To-Earnings Ratio (19.5x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst SFZN1 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCHF 98.00
CHF 114.58
+16.9%
12.7%CHF 142.00CHF 94.50n/a11
Apr ’26CHF 89.90
CHF 114.81
+27.7%
12.2%CHF 142.00CHF 94.50n/a12
Mar ’26CHF 96.10
CHF 115.10
+19.8%
12.6%CHF 142.00CHF 94.50n/a12
Feb ’26CHF 102.80
CHF 116.77
+13.6%
13.6%CHF 150.00CHF 90.00n/a12
Jan ’26CHF 98.60
CHF 118.77
+20.5%
11.6%CHF 150.00CHF 99.00n/a12
Dec ’25CHF 111.40
CHF 118.77
+6.6%
11.6%CHF 150.00CHF 99.00n/a12
Nov ’25CHF 115.00
CHF 118.77
+3.3%
11.6%CHF 150.00CHF 99.00n/a12
Oct ’25CHF 114.40
CHF 116.28
+1.6%
11.8%CHF 150.00CHF 99.00n/a12
Sep ’25CHF 111.80
CHF 107.52
-3.8%
7.8%CHF 118.80CHF 90.00n/a13
Aug ’25CHF 102.40
CHF 104.10
+1.7%
8.9%CHF 118.80CHF 88.00n/a12
Jul ’25CHF 94.40
CHF 101.59
+7.6%
7.4%CHF 112.50CHF 88.00n/a10
Jun ’25CHF 89.90
CHF 101.59
+13.0%
7.4%CHF 112.50CHF 88.00n/a10
May ’25CHF 88.20
CHF 101.59
+15.2%
7.4%CHF 112.50CHF 88.00CHF 98.0010
Apr ’25CHF 92.10
CHF 100.54
+9.2%
7.8%CHF 112.50CHF 88.00CHF 89.9011
Mar ’25CHF 90.50
CHF 96.45
+6.6%
7.2%CHF 105.00CHF 82.00CHF 96.1011
Feb ’25CHF 84.60
CHF 91.16
+7.8%
8.4%CHF 100.00CHF 80.00CHF 102.8010
Jan ’25CHF 85.95
CHF 89.12
+3.7%
7.5%CHF 99.00CHF 80.00CHF 98.609
Dec ’24CHF 78.25
CHF 88.19
+12.7%
7.4%CHF 99.00CHF 80.00CHF 111.408
Nov ’24CHF 71.45
CHF 88.19
+23.4%
7.4%CHF 99.00CHF 80.00CHF 115.008
Oct ’24CHF 78.45
CHF 87.19
+11.1%
7.8%CHF 99.00CHF 80.00CHF 114.408
Sep ’24CHF 78.90
CHF 86.06
+9.1%
11.8%CHF 99.00CHF 64.00CHF 111.809
Aug ’24CHF 76.95
CHF 81.75
+6.2%
11.9%CHF 94.50CHF 64.00CHF 102.408
Jul ’24CHF 73.90
CHF 81.31
+10.0%
12.0%CHF 94.50CHF 64.00CHF 94.408
Jun ’24CHF 73.40
CHF 81.50
+11.0%
12.7%CHF 94.50CHF 64.00CHF 89.907
May ’24CHF 68.65
CHF 80.50
+17.3%
12.2%CHF 94.50CHF 64.00CHF 88.207
AnalystConsensusTarget
Consensus Narrative from 11 Analysts
CHF 114.58
Fair Value
14.5% undervalued intrinsic discount
11
Number of Analysts

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/02 13:17
End of Day Share Price 2025/04/30 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Siegfried Holding AG is covered by 22 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Thomas MeyerBaader Helvea Equity Research
Volker BosseBaader Helvea Equity Research
Laura Lopez PinedaBaader Helvea Equity Research